Shivamani Pharma Pack Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 07-12-2024
- Paid Up Capital ₹ 2.78 M
as on 07-12-2024
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.00 M
as on 07-12-2024
- Revenue 32.59%
(FY 2022)
- Profit -54.50%
(FY 2022)
- Ebitda 15.75%
(FY 2022)
- Net Worth 6.97%
(FY 2022)
- Total Assets -6.37%
(FY 2022)
About Shivamani Pharma Pack
The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.78 M.
The company currently has active open charges totaling ₹6.00 M.
Vipin Mathur, Meeta Mathur, and Rakesh Shrivastava serve as directors at the Company.
- CIN/LLPIN
U52390GJ2014PTC079875
- Company No.
079875
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jun 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Bharuch, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Shivamani Pharma Pack?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Shrivastava  | Director | 01-Mar-2018 | Current |
| Vipin Mathur | Director | 23-Jun-2014 | Current |
| Meeta Mathur | Director | 29-Dec-2021 | Current |
Financial Performance of Shivamani Pharma Pack.
Shivamani Pharma Pack Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.59% increase. The company also saw a substantial fall in profitability, with a 54.5% decrease in profit. The company's net worth moved up by a moderate rise of 6.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shivamani Pharma Pack?
In 2021, Shivamani Pharma Pack had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shivam Consultants & Logistics Private LimitedActive 16 years 1 monthVipin Mathur and Meeta Mathur are mutual person
Saigal Exim Private LimitedInactive For E-Filing 8 months 28 daysVipin Mathur and Meeta Mathur are mutual person
- Symbiosis Enterprises Private LimitedActive 22 years 29 days
Vipin Mathur and Meeta Mathur are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 06 Mar 2024 | ₹6.00 M | Open |
How Many Employees Work at Shivamani Pharma Pack?
Unlock and access historical data on people associated with Shivamani Pharma Pack, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shivamani Pharma Pack, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shivamani Pharma Pack's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
